INmune Bio (INMB) IPO Opens at $8.44
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
Go back to INmune Bio (INMB) IPO Opens at $8.44
February 4, 2019 8:55 AM EST
LA JOLLA, CA, Feb. 04, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (INmune or the Company), an immunotherapy company focused on developing therapies that harness the patients innate immune system to fight disease, today announced that the Companys common stock is expected to commence trading on The Nasdaq Capital Market, on Monday, February 4, 2019 under the ticker symbol INMB.
On February 1, 2019, INmune closed its initial public offering (IPO) of 1,020,560 shares of its common stock at of $8.00 per share for a total of $8,166,560 in gross proceeds before placement agent fees and offering expenses.
Univest Securities, LLC... More
February 4, 2019 8:55 AM EST
LA JOLLA, CA, Feb. 04, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (INmune or the Company), an immunotherapy company focused on developing therapies that harness the patients innate immune system to fight disease, today announced that the Companys common stock is expected to commence trading on The Nasdaq Capital Market, on Monday, February 4, 2019 under the ticker symbol INMB.
On February 1, 2019, INmune closed its initial public offering (IPO) of 1,020,560 shares of its common stock at of $8.00 per share for a total of $8,166,560 in gross proceeds before placement agent fees and offering expenses.
Univest... More
